Vnitr Lek 2018, 64(9):874-877 | DOI: 10.36290/vnl.2018.120

Arrhythmias and conductance disturbances and heart failure

Jiří Vítovec1,*, Jindřich ©pinar2, Lenka ©pinarová1
1 I. interní kardio-angiologická klinika LF MU a FN u sv. Anny v Brně
2 Interní kardiologická klinika LF MU a FN Brno, pracoviątě Bohunice

Arrhythmias and conductance disturbances and heart failure have a close relation. Arrhythmias are serious complication, but also etiology of heart failure. So it is not clear, what is the cause and what is a consequence. Atrial fibrillation is a frequent cause, ventricular arrhythmias a frequent consequence and ventricular fibrillation a frequent cause of death in patients with heart failure. Overview are about frequent arrhythmias as well as their therapy with regard to left ventricular dysfunction.

Keywords: arrhythmias; heart failure

Received: July 19, 2018; Accepted: August 13, 2018; Published: September 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Vítovec J, ©pinar J, ©pinarová L. Arrhythmias and conductance disturbances and heart failure. Vnitr Lek. 2018;64(9):874-877. doi: 10.36290/vnl.2018.120.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Ponikowski P, Voors AA, Anker SD et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016; 37(27): 2129-2200. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw128>. Go to original source... Go to PubMed...
    2. ©pinar J, Hradec J, ©pinarová L et al. Summary of the 2016 ESC Guidelines on the diagnosis and treatment of acute and chronic heart failure. Prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(5): e530-e568. Dostupné z DOI: <https://doi.org/10.1016/j.crvasa.2016.09.004>. Go to original source...
    3. Vítovec J, ©pinar J, ©pinarová L et al. Léčba kardiovakulárníchh onemocnění. Praha: Grada Publishing 2018. ISBN 978-80-271-0624-0.
    4. Smit MD, Moes ML, Maass AH et al. The importance of whether atrial fibrillation or heart failure develops first. Eur J Heart Fail 2012; 14(9): 1030-1040. Dostupné z DOI: <http://dx.doi.org/10.1093/eurjhf/hfs097>. Go to original source... Go to PubMed...
    5. Hess PL, Jackson KP, Hasselblad V et al. Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis. Curr Cardiol Rep 2013; 15(2): 330. Dostupné z DOI: <http://dx.doi.org/10.1007/s11886-012-0330-6>. Go to original source... Go to PubMed...
    6. Connolly SJ, Camm AJ, Halperin JL et al. Dronedarone in high-risk permanent atrial fibrillation. N Engl J Med 2011; 365(24): 2268-2276. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1109867>. Go to original source... Go to PubMed...
    7. Hofmann R, Steinwender C, Kammler J et al. Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate. Int J Cardiol 2006; 110(1): 27-32. Dostupné z DOI: <http://dx.doi.org/10.1016/j.ijcard.2005.06.048>. Go to original source... Go to PubMed...
    8. Kirchhof P, Benussi S, Kotecha D et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016; 37(38): 2893-2962. Dostupné z DOI: <http://dx.doi.org/10.1093/eurheartj/ehw210>. Go to original source... Go to PubMed...
    9. Roy D, Talajic M, Nattel S et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 2008; 358(25): 2667-2677. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa0708789>. Go to original source... Go to PubMed...
    10. Marrouche NF, Brachmann J, Andresen D et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med 2018; 378(5): 417-427. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa1707855>. Go to original source... Go to PubMed...
    11. Čihák R, Haman L, Táborský M. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Summary of the document prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(6): e636-e683. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crvasa.2016.11.005>. Go to original source...
    12. Kautzner J, Osmančík P. Summary of the 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Prepared by the Czech Society of Cardiology. Cor Vasa 2016; 58(1): e29-e80. Dostupné z DOI: <http://dx.doi.org/10.1016/j.crvasa.2016.01.009>. Go to original source...
    13. Táborský M, Kautzner J. Summary of the 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Prepared by the Czech Society of Cardiology. Cor Vasa 2014; 5(1): e57-e74. Dostupné z DOI: <https://doi.org/10.1016/j.crvasa.2013.12.001>. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.